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Abstract 
 
In this paper two case studies are compared, Mexico and Colombia, in which the protection of 
‘genetic identities’ has generated political and legal systems designed to avoid the unlawful 
appropriation of biological material and/or DNA in Latin America. The very idea that genetic 
patrimonies belong to nation-states or ethno-racial groups —framed as genomic sovereignty or the 
protection of a disappearing indigenous genetic heritage— is the product of a genetically reified 
understanding of human diversity, which we identify as ‘biocoloniality’. By exploring the common 
tropes and imaginations with which biocoloniality has been articulated, we argue that governance 
mechanisms built around ‘genetic identities’ are ineffective in addressing the unequal power 
relations inherent in contemporary scientific and regulatory practice. 
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Introduction  
 
 The idea that genomic and genetic technologies offer new ways to characterise the biological 
‘uniqueness’ of individuals and populations, has been rapidly incorporated into the managerial and 
regulatory practices of fields as diverse as forensics, law and medicine. By the same token, ‘genetic 
uniqueness’ has firmly entered into the legal mechanisms designed to protect the commercially 
valuable and/or endangered human genetic patrimony of ‘developing countries’, ‘ethnic minorities’ 
or ‘the global south’ against emerging biocolonial threats (Seguín et al. 2008; Hardy et al. 2008). In 
this paper we argue that the idea that genetic patrimonies ‘belong’ to nation-states or ethno-racial 
groups is the product of a genetically reified framing of human diversity, which may be open to 
racialised conceptions. This is a process that we have named biocoloniality, which is a notion that 
emerges both from the literature on coloniality (Quijano 2000) and biopolitics (Foucault 2007). 
 
The Peruvian sociologist Aníbal Quijano (2000) coined the concept of ‘coloniality of power’ to 
bring into focus the relationships between power and the contemporary constitution of the world-
system, which has configured the labour force, its geographies, knowledge and subjectivities along 
racialised lines. Racialisation is a central element in Quijano’s analysis of coloniality, since it 
provides the historical basis on which relations of domination became naturalised from the sixteenth 
century onwards, first in the Americas and then globally. Quijano argues that over the span of three 
hundred years the imposition of racial taxa amalgamated a multitude of different groups (e.g. 
Mayans, Aztecs, Chibchas) into one category (e.g.. Indians), producing at once the legitimating 
logic for specific forms of labour —such as serfdom for Indians, or slavery for Blacks— 
fundamental for global capitalist accumulation, and a new ‘modern’ perspective of knowledge 
“within which non-Europe was the past, and because of that inferior, if not always primitive” (2000: 
552). According to Quijano, Cartesian thought established a strict dualist ontology that separated 
body/nature/object from reason/subject, allowing for a version of Eurocentrism in which some 
(non-European) races were seen as closer to nature, and were therefore suitable to become objects 
of knowledge and of domination and exploitation (Quijano 2000:555). On this view, modernity is 
inextricably associated with —and mutually constitutive of— coloniality. Moreover, racialisation, 
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including its modern variants, has proved to be more durable than the colonial matrix in which it 
was established, producing new and sometimes more subtle power mechanisms in which the old 
dichotomies between coloniser and colonised no longer apply. Therefore, coloniality should be 
understood as a much more complex phenomenon than colonialism, one that indeed extends to the 
present, operating through civilisatory dispositifs, with both ontological (coloniality of being) and 
epistemological (coloniality of knowledge) dimensions, bringing forth different kinds of 
Eurocentrism (Mignolo 2001). One of the ways in which such mechanisms operate is by mobilising 
and privileging histories of colonial domination or linear ideas of progress to understand the 
present. But they are also apparent whenever human diversity is organised along a racial axis. 
 
Building on this theoretical perspective, Juan Camilo Cajigas (2007) proposed the concept of 
‘biocoloniality of power’, understood as: “the current production of nature under the framework of 
post-Fordist capitalism” (2007:169). However, we suggest that this concept needs further 
elaboration, by paying closer attention to how the Foucauldian notion of biopolitics (Foucault 2007) 
intersects with and operates through a colonial matrix of power (Quijano 2000). Biocoloniality 
recovers how elements of coloniality are constitutive of the scientific making of populations, 
producing ‘genetic identities’ (especially those linked to existing discourses of race and nation) 
which are understood as being in need of protection and/or preservation from capitalist 
expropriation or the unruly circulation of biocapital (Sunder-Rajan 2006). In the present paper,  we 
argue that, despite its apparent emancipatory promise, the creation of ‘genetic identities’ and the 
legal schemes designed to protect them —crafted at the cross roads of science and politics— 
necessarily reintroduces and reinforces racialised-modern dualisms, and with them elements of 
coloniality. 
 
In defining biocoloniality in this way, two further points should be borne in mind.  First, as many 
geneticists have argued, genetically unique populations do not exist prior to their description by 
scientists, which necessarily involves social and political presuppositions and assumptions.  On the 
one hand, human populations are not discrete biological entities, but are genetically continuous with 
one another; on the other, genomic analysis of any two arbitrarily demarcated groups will yield 
statistically significant allelic differences (Duster 2005). Consequently, we need to look beyond the 
prowess of genetic technologies to understand why claims are made about ‘uniqueness’ or the 
boundaries of populations. This is borne out by Amy Hinterberger’s (2012) analysis of Canadian 
genomics and the scientific mobilisation of Quebec’s founding population, which provides a vivid 
account of how the “uniqueness” of that population emerged from research driven by European 
venture capitalists and disseminated by research groups linked to Canadian funding agencies, which 
depended on enrolment of different types of census categories and registers of national-colonial 
history. Hinterberger’s account of how this genetic population acquired meaning at the nexus of 
empire, census and multicultural policies in Canada is consistent with our concept of biocoloniality.  
 
Secondly, the concept of biocoloniality differs from recent critiques of biocolonialism in a key 
respect. Accounts of biocolonialism suppose that, “with molecular genetics, a unique type of 
identification and differentiation has come about in which individuals and populations can be 
uniquely analyzed and regulated” (Thacker 2005: 163-164). The literature on biocolonialism thus 
supposes a discontinuity with older forms of colonialism and a ‘new’ biocolonialism brought forth 
by molecular genetics. By contrast, the concept of biocoloniality draws on Foucault’s observation 
that biopolitics have always been about the management and exploitation of the life of populations. 
On this view, claims about novel forms of biocolonialism in the global south do not emerge solely 
because of the novel molecular capacities of our age; rather, they are themselves the product of the 
overlap of different notions of modernity, nationhood and colonial awareness, enacted according to 
the exigencies of different political environments.  
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In the present paper, we explore and illustrate the workings of biocoloniality through two case 
studies—Mexico and Colombia— in which the articulations between nationhood, ethno-racial 
difference, and genetics became the grid of intelligibility on which scientific research, alongside 
political disputes over ‘new types’ of colonialism, were plotted. First, we describe a scientific 
project known as The Human Expedition (1988-1994) that sought to uncover a “deep” Colombia 
made of isolated populations threatened by globalisation and mestizaje (roughly, cultural and racial 
mixture).  
 
Drawing on documentary sources and archival research, contextualised by insights from individual 
and group interviews including with those involved in the HE project, we argue that although the 
Human Expedition (HE) had a strong humanist and multiculturalist orientation (Wade et al. 2014, 
chapter 8) and had no intentions to make commercial profits, its discourse on “salvage genetics” 
unleashed a confrontation between NGOs, indigenous communities, and scientists. This controversy 
ultimately led to the demise of the HE and to legal reforms for the protection of the ‘genetic 
material of ethnic minorities’, due to allegations that geneticists had misused ethnic minority 
samples in order to obtain commercial profit.   
 
In the case of Mexico, we explore the institutionalisation of the Mexican Institute of Genomic 
Medicine (INMEGEN). This case study is based on more than two years (August 2008-November 
2010) of participant observation at INMEGEN’s Ethical Legal and Social Issues (ELSI) Centre and 
its Population Genomics Laboratory (PGL), and on semi-structured interviews with key actors in 
the Mexican genomics arena: policy makers, genomic scientists, NGOs and public critical voices. 
We show how mobilisation of the notion of ‘genomic sovereignty’ fuelled a national law of health 
(D.O.F. 2008) to protect “The Mexican Genome” from “unscrupulous capitalist interests” (D.O.F. 
2001), as well as an international policy agenda to defend the genetic patrimony of the global south 
(Hardy et al. 2008).  
 
Genealogical analysis of these two contrasting cases is especially valuable for understanding the 
workings of biocoloniality for two reasons. First, while the HE was the earliest large scale-national 
population genetics project in Latin America, it was ultimately unsuccessful in securing indigenous 
samples. By contrast, in Mexico 20 years later it was possible to create one of the largest population 
genetics project in the global south, despite criticism coming from the same international NGO and 
local indigenous groups as objected to the HE. Secondly, while the concept of mestizaje plays a 
preponderant role in the constitution of national imaginaries in both countries, differential 
articulations of genetics, nation, race and mestizaje (see Wade et al. 2014) materialised in divergent 
regulations designed to avoid the unlawful acquisition of ‘national’ DNA in Mexico, or ‘ethnic’ 
genetic material in Colombia. This allows us to flesh out the complex interplay between collective 
(geneticised) identities, national imaginaries and political possibilities that characterises 
biocoloniality across different settings.  
 
Drawing on this analysis, we conclude by proposing that instead of creating laws that fix ‘genetic 
identities’ in need of protection, Latin American countries, as well as the global south, should start 
developing governance mechanisms that respond to: 1) the global and local production of genetic 
knowledge; 2) the technical and ethical impossibility of isolating the ‘genetic uniqueness’ of any 
population in the world; and 3) the lack of robust policies and institutional mechanisms to deal with 
the huge socio-economic asymmetries that still characterise many of the countries in the global 
south. 
 
The Human Expedition: Colombia and the genetic search for a ‘deep’ nation (1988-1994) 
The Human Expedition 1992 […] seeks to identify the genetic foundation that defines the 
Amerindian, black, and mestizo races that inhabit our territory, as well as the ethnography of 
the Colombian man (Gómez 1992: 10). 
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The project known as the Expedición Humana or Human Expedition (HE) was one of the 
milestones of genetic research in Colombia. This project, which lasted from the end of the 1980s 
through the first half of the 1990s, sought to explore the diversity of the Colombian population, not 
only in terms of molecular genetics but also in relation to cultural aspects. What began as a 
population genetics project undertaken by a small group of experts turned into a large, 
interdisciplinary research and medical/social service program, known first as the Human Expedition 
1992 (1988-1992) and then as the Great Human Expedition (GHE, 1993-1994). Entirely funded by 
the Pontificia Universidad Javeriana (PUJ), the program consisted of ‘expeditions’ to marginal 
areas to visit certain ‘isolated communities’ (many of which were indigenous) in an effort to 
undertake a series of genetic studies that, almost always, were accompanied by a medical and dental 
team that provided free care. The central premise of the program was articulated in terms of 
knowing and valuing the ‘diversity’ of the ‘Colombian population’ —especially its indigenous and 
black communities —and although the genetic component was at the centre of its objectives, it was 
not the only research aspect considered: 
  
The Fifth Centenary of the Encounter of Two Worlds was key to take an important step 
forward in the Human Expedition in order to make better sense of all the knowledge that 
has been acquired over these years, turning Colombia’s attention to the situation that our 
isolated communities live in, and looking for sources of solutions to some of their most 
important needs. For this, we have planned a Great Human Expedition that will cover all 
the previously visited territories in order to continue our research process, to enable our 
isolated communities to find interlocutors that can aid them in their process of self-
empowerment, and to produce a graphic archive that will give other Colombians a clear 
idea of their multi-ethnicity (Bernal 1990: 2). 
 
The GHE disseminated the idea that the Colombian nation needed to learn about population groups 
with relatively uncontaminated gene pools. This “deep” Colombia stood in contrast to another 
unmarked, mainstream—implicitly mestizo—nation. For the scientists of the GHE, indigenous 
genetic diversity was at great risk of disappearing due to the attacks of the contemporary world’s 
technological transformations and the accelerated mestizaje (biological and cultural admixture) 
affecting these ‘isolated communities’. This approach provided the grounding on which scientific 
initiatives such as the GHE and the creation of an “Amerindian” blood-bank were mobilised: “The 
conservation of all of this biological patrimony is truly urgent, given that the various ethnic groups 
run the risk of being diluted amidst the progressive mestizaje of these cultures” (PUJ 1992: 16). The 
following citation from a research proposal presented by the IGH- PUJ provides another vivid 
example: 
 
It is no mystery that the populations that inhabited our continent before Columbus’s arrival 
have gradually become extinct, whether through acculturation and incorporation into cities 
and towns, or due to the high morbidity and mortality of infectious diseases and malnutrition 
that followed the disruption of their habitat wrought by ‘white’ colonos (settlers). The 
medical and genetic study of these populations is therefore urgent, and this becomes even 
clearer when we consider that indigenous settlements in other parts of the continent have 
been the object of these kinds of studies for over twenty years while nothing similar has been 
carried out in Colombia. (Bernal 1991: 3) 
 
This ‘salvage genetics’ was heir to the anthropological anxiety of the mid twentieth century, which 
was concerned with the seemingly evident disappearance of traditional indigenous groups. This 
anxiety was the driving force behind countless ‘salvage ethnographies’ that, in the name of science 
and humanity, sought to preserve a proper account of those populations that were allegedly 
disappearing. In anthropology, this discourse was deeply questioned in light of the resilience and 
even resurgence of indigenous groups, but in the Human Expedition it re-emerged as an argument 
that substantiated the need for clinical and population genetics research. As a consequence, genetic 
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research became part of an effort to unveil and protect the biological diversity of the Colombian 
nation (cf. Restrepo, Schwartz-Marin & Cardenas 2014). 
  
In the 1990s, an international NGO named the Erosion Technology and Concentration  (ETC) group 
(formerly called Rural Advancement Foundation International, RAFI), devoted to restricting the 
appropriation of the biological resources of the global south, became interested in the HE. In 
general terms the ETC frames its endeavour as a constant struggle against biopiracy (a term coined 
by Pat Mooney, ETC’s CEO, in 1993), understood as:  
 
the use of intellectual property systems to legitimize the exclusive ownership and control of 
biological resources and knowledge, without recognition, compensation or protection for 
contributions from indigenous and rural communities [...] thus bioprospecting cannot be 
considered anything but biopiracy (Pat Mooney in Delgado, 2002: 299).  
 
The ETC has been quite the global actor. In the 1990s this NGO disputed the patenting of the 
Hagahai cell line (Anderson 2012), and at the same time helped in the organisation of indigenous 
groups opposing The Human Genome Diversity Project (HGDP) in the US and the HE in 
Colombia. The HGDP deserves special mention, since it was an international endeavour which 
aimed to look for genetic variation in ‘isolated populations’, mostly indigenous groups around the 
world, in order to preserve the history of humanity through indigenous DNA. The way in which its 
promoters approached the topic of preservation of indigenous DNA generated an international 
controversy in which indigenous communities thought they were being treated as relics faced with 
extinction, rather than human communities facing serious medical and socioeconomic challenges. 
The disputes with the ETC and indigenous groups finally paralysed the HGDP (see Reardon 2005; 
M’charek 2005). 
 
Although the HE struggled to avoid being linked to the HGDP, very similar political disputes 
haunted them, since both projects endorsed a ‘salvage genetics’ discourse. In 1996 the ETC group 
and Senator Lorenzo Muelas — who was at the time an indigenous representative— accused the 
GHE of sending indigenous blood samples to US institutions without proper informed consent. The 
public precedent for this accusation was a documentary film first shown on BBC in 1994, titled The 
Gene Hunters. In this film GHE members were portrayed as intermediaries for the collection of 
indigenous blood samples, sending the samples to foreign institutions with economic interest in 
them (Ramos 2004: 24) - an portrayal that the GHE scientists systematically denied.  
 
One of the implications of The Gene Hunters was that private interests would commercialise 
indigenous samples in ways that could ultimately harm indigenous people in Colombia (see Ramos 
2004, Barragán 2011). Consequently, the ETC group and indigenous representatives demanded the 
return of samples collected by the HE, since according to them, indigenous communities were being 
used as raw material for a new colonial era in which genes were being patented to gain commercial 
profit. For their part, indigenous representatives thought that the challenges they faced had nothing 
to do with the stated commitments of the HE — to empower them and make them visible to others 
— but rather stemmed from efforts to make them objects of western knowledge, which in their view 
had been historically used to systematically plunder their resources:  
 
The problem of our people is not that we are hidden, our problem is economic 
exploitation, political oppression and cultural denial; it is the problem of gigantic poverty, 
not because we have always been poor, we have rather been impoverished by them 
through a systematic plundering of all our patrimony. Besides, our experience tells us that 
simply knowing the other, does not guarantee its respect, because knowledge can be, and 
in fact it has been, the foundation for a better exploitation, an experience from which we 
cannot exclude those that claim to act under Christian values. We should not forget that it 
is precisely in the name of that moral and those Christian values that the toughest blows 
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have been given to our thoughts, institutions and customs (Muelas and Green 1996- 
indigenous representatives). 
 
Although almost twenty years have gone by and the accusations made against the HE were 
unfounded, these public controversies left a mark in the tacit protocols and legislation regulating 
research with indigenous communities in Colombia. These included the law 599 of 2000, which 
sanctioned with 1 to 5 years of jail “any manipulation of genes without free and informed consent” 
(Barragan 2011: 46).  
 
The history of the HE and its aftermath vividly illustrates the workings of biocoloniality. This is 
apparent in the HE’s scientific imagination, which clearly located indigenous people’s DNA in a 
pre-modern past, and which sought to create a biobank to protect it from dilution by the modern 
forces of globalisation and admixture. But biocoloniality also shaped critical as well as scientific 
discourses: it was by invoking colonial history (rather than actual practices of commercial 
exploitation) and reinforcing modern-racialised dualisms (including the idea of indigenous DNA) 
that critical voices made their point. 
 
INMEGEN and the search for Genomic Sovereignty in Mexico (2001-2009) 
 
As a consequence of ethnic and geographic differences between allelic frequencies amongst 
persons and even whole populations, both [individuals and populations] could be exposed to 
ethical dangers. Actions that go against the most basic ethical principles are already 
becoming possible, and these dangers will increase exponentially as the HGP [Human 
Genome Project] reaches its end (IFS 2001:10). 
 
Mexico has a population of unique genomic makeup as a result of its history (Jimenez-
Sanchez 2002: 32; emphasis added). 
 
After 18 months of negotiations inside the Mexican Congress, the Mexican Institute of Genomic 
Medicine (INMEGEN) became the country’s eleventh National Institute of Health on April 24th 
2004. It was finally funded with more than 120 million dollars for its first 5 years of existence (see 
López-Beltrán, Vergara-Silva & García-Deister 2014; Schwartz-Marin 2011). According to the 
presidential decree mandating its creation, the duty of INMEGEN was to “promote, regulate, foster 
and practice the research and medical applications derived from the knowledge of the human 
genome” (D.O.F., 2004: Article V-bis). The decisive support of the Congress was accompanied by 
claims that there was a “biological uniqueness” inherent in the Mexican nation that needed urgent 
legal protection. This claim was publicly sustained by invoking historical experiences of 
dispossession, stressing the need to protect national interests against foreign exploitation: 
 
Great priority should be given to the collection and study of Mexican germplasm, by our 
own scientists, without hindering international collaborations; but avoiding at all costs 
that this national resource becomes appropriated and used in an almost exclusive fashion 
by foreign researchers as has happened before in archaeology, botany or zoology 
(INMEGEN Feasibility study [IFS], 2001: 25). 
 
In response to what congressmen and scientists thought could be the most likely threats released by 
the new genomic era, a political and legal ethos known as ‘genomic sovereignty’ was designed to 
avoid the unlawful appropriation of Mexican DNA. The idea behind genomic sovereignty was that, 
with the completion of the Human Genome Project (HGP), the commoditisation of genetic 
information was now possible. This meant genomics could become a tool to oppress possible 
consumers and citizens in developing or emerging economies. Previous examples of colonial 
exploitation of Mexico’s biological resources, including the cultivation of Barbasco for the 
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production of synthetic steroids by the Syntex pharmaceutical company (see Soto-Laveaga 2009), 
figured prominently in the new discourse of genomic sovereignty.  
 
In Mexico, biocoloniality thus involved the mobilisation of a colonial history – including 
longstanding concerns about national autonomy and unsuccessful efforts to become an actor in the 
global scientific arena – and the invocation of possible colonial futures, along with the framing of a 
distinct national genetic heritage. In contrast to the Colombian case, however, it was not critical 
voices but scientific and political elites who summoned these ideas in order to support and extend a 
nationalistic version of genomic research. Thus Dr. Gerardo — founder and first director general of 
INMEGEN — said that genomic sovereignty was a concept developed to avoid foreign researchers 
coming to the country to “plunder indigenous blood and samples” (Interview 2008). In other public 
venues he also defended the notion of genomic sovereignty as a guiding principle to share and 
promote the benefits of genomic medicine with indigenous communities (Jimenez-Sanchez, 
presentation at the Academia Nacional, July 2nd, 2009). Similar sentiments pervaded the lobbying 
process in Congress, which constantly mobilised the idea that the genetic heritage of the Mexican 
nation was an asset, a ‘national resource’ in the new bioeconomies (OECD 2006). This discourse 
was also notably racialised, sometimes exalting the strong indigenous roots of Mexicans and at 
other times showcasing the unique patterns of racial admixture (Schwartz-Marin 2008, 2011). A 
quotation taken from one of the speeches given in the Congress by Marcia Muñoz —advocate and 
lobbyist for INMEGEN — provides a clear example of this negotiation strategy:  
 
you saw the potential that lies in the Mexican population, because of its indigenous 
origins...as genomes are more concentrated, they possess more research value [...] Mexico 
has to define the profile of its populations and also of its values...if there is not an 
appropriate legislation, imagine what would happen if a laboratory came to patent that 
valuable knowledge and take it to other places, taking away also  indigenous genes [...] as 
science moves forward, legislation is needed (Muñoz in Canal del Congreso 2002). 
 
This construal of genomic sovereignty and genetic uniqueness proved to be a successful lobbying 
strategy. The first step towards achieving sovereignty was the creation of INMEGEN in 2004. As 
one commentator declared: 
 
A Mexican genomic platform is considered key to discouraging non-Mexican research 
and development of Mexican-specific products and services. Anecdotal reports indicate 
that U.S. field workers have, in the past, collected blood samples from Mexican 
indigenous populations and taken the samples back to the United States. Presumably, 
polymorphisms could be identified and genomic-specific medicines made and sold at 
U.S. prices. If this were to happen, Mexicans would likely not be able to afford the drugs, 
thereby worsening economic and inequity problems that already exist. (US-NRC 2005: 
10-12). 
 
This was quickly followed by the inception of a programme to produce a genetic map of Mexican 
mestizo difference.  Despite a generalised rejection amongst geneticists and biomedical scientists 
of the existence of a discrete ‘Mexican genome’, the Mexican Genome Diversity Project (MGDP), 
launched in 2005 in order to produce a catalogue of genetic variation to serve national interests, 
effectively brought this concept into common usage.  
 
Research for the MGDP soon gave additional impetus to concerns about genomic sovereignty. 
According to top officials and in-house bioethicists, it was during the Mexican Genome Sampling 
Journeys that they found out that the privately funded Genographic Project – a ‘genetic 
anthropology’ venture run by the National Geographic Society – had been giving “Tupperware” and 
a few dollars to indigenous communities in exchange for their blood samples (field notes, 
December 2008). Another source of political and commercial anxiety was the patent permission 
requested from the Mexican office of intellectual property by Myriad Genetics on BRCA 1-BRCA 
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2 genes, a question that stirred fears of biocolonialism: “It was not only the plundering of 
indigenous communities but the hegemony of one nation over another for the genomic knowledge, 
taking shape with concrete examples, products and populations!” (Jimenez-Sanchez, interview 
2008).  
 
As a concrete response to these threats, in 2008 the Mexican Congress passed the so-called law of 
Genomic Sovereignty in a record time of 6 months. The move from a diffuse relation between 
national security and Mexican uniqueness to a law embedding sovereignty in the genetic material, 
available in “corpses, blood samples or human tissue” (D.O.F. 2008), was a pragmatic response to 
biopiracy, or what the INMEGEN calls Safari Research. On INMEGEN’s web page the intentions 
of the law were explained as follows:  
 
[the law] recognises that national sovereignty must include everything related to the 
genetic material of Mexicans. Therefore, in the light of the misuse of information it is 
very important to prevent the biological material and information derived from it from 
being transferred outside the country without regulation (www.inmegen.gob.mx; last 
consulted on the 10th of March 2011). 
 
Strikingly, such measures resulted in further disagreement over just what was meant by 
‘sovereignty’. For experienced policy makers and international figures such as Dr. Julio Frenk 
Mora— former Mexican Secretary of Health— the search for sovereignty was actually to be found 
in a cosmopolitan ethos of international cooperation and mutual legal responsibility (Frenk-Mora, 
interview 2009). For others, however – including scientific bodies, former members of the 
INMEGEN, and the ETC group – the idea of sovereignty, including the prickly question of who 
was really getting a benefit— was much less clear. The ETC group had been active in Mexico since 
the 1970s, particularly in matters of bio-prospecting, indigenous knowledge and green biotech (cf. 
Hayden 2003). As soon as INMEGEN’s MGDP was announced, the ETC dubbed this another 
“vampire project”. The relationship of INMEGEN with transnational enterprises and its ties with 
the National Foundation for Health (FUNSALUD), the largest private health-related think-tank in 
Mexico, strengthened ETC’s suspicion. For the ETC, the discourse of Mexican sovereignty was just 
a mask for a non-altruistic enterprise in which Mexican geneticists were plundering the indigenous 
genetic heritage of the country, with the help of transnational pharmaceuticals:  
 
I do not know what they mean by ‘Genomic Sovereignty’, but evidently what there is, is 
an interest of great corporations [...] the genes are indigenous and the results are all 
transnational! Those projects have not benefited—and will not benefit at all—indigenous 
populations. But, on the other hand, the researchers have benefited themselves through 
publications, academic credits and scholarships, and the institutions have got the 
justification to ask for more public resources. In both cases they produce information that 
is later capitalised by the pharmaceutical corporations (Silvia Ribeiro [ETC researcher in 
Mexico and Latin America], interview 2008).  
 
Artemio Cruz (pseudonym)—designer of the law and former founding member of INMEGEN— as 
well as various scientific groups, also argued that the law was a tool for manipulating and 
monopolising genomic research, since a fundamental clause dealing with intellectual property was 
absent (Schwartz-Marín & Arellano-Mendez 2011).  
 
Regardless of the position taken towards the possible uses of human genetics, however, the 
processes of racialisation that are central to biocoloniality were already present from the moment 
when political actors in the Mexican genomics arena accepted that a “genetic patrimony” lies in the 
genomic structure(s) of a national population (mestizo and/or indigenous groups). In the Mexican 
case, biocoloniality, involving the articulation of a racialised Mexican uniqueness, is apparent as 
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much in efforts to formulate a scientific and legal defence of Mexican national autonomy as in more 
obviously biocolonial threats to that autonomy. 
 
Biocoloniality and the racial construction of genetic patrimonies 
 
Research into ‘genomic sovereignty’ policies in the global south makes clear that, regardless of 
whether we consider Mexico (Schwartz-Marin & Arellano-Mendez 2012), South Africa (DeVries 
& Pepper 2012), or India (Egorova 2010), the genomic criteria to delimit the boundaries of Mexican 
DNA, African genetics or Indian castes are elusive, if not impossible to find. Adopting a global 
perspective, Ruha Benjamin (2009) describes ‘genomic sovereignty’ policies as processes of 
strategic calibration in which proponents try to make socio-political and biological categories 
coincide, in order to construct their own national biomedical niche markets. Our genealogical 
analysis of the Mexican and Colombian cases in terms of biocoloniality suggests a broader 
perspective. Although the HE and the MGDP projects developed in very different historical and 
socio-technical contexts, the constitution of ‘genetic identities’ was not limited to what their 
proponents wanted to do with them in order to accumulate cultural or monetary capital. In each of 
these very different case studies, we can see how biocoloniality not only limited and shaped 
scientific enquiry, including the boundaries of  genetic populations; it also shaped the character of 
political disputes and governance regimes. Genomic studies in Colombia and Mexico deployed 
concepts of population - indigenous people, Europeans, Africans, mestizos - that were open to 
racialised readings (indeed the term raza was used occasionally by some HE scientists in the early 
1990s) and these categories brought with them a baggage of colonial history.  
 
Although both projects were dubbed “vampire projects” by the ETC (despite very different uses of 
informed consent practices, scientific aims and technological capabilities), the way in which race 
and nation were coupled in each nation-state provided very different grounds to fight ‘biopiracy’ or 
defend indigenous rights. Thus, in the Colombian case, the deleterious effects of mestizaje on the 
genetic patrimony of isolated populations was presented as an argument for the creation of an 
Amerindian biobank, producing a “salvage genetics” to preserve the diversity of the nation and the 
“uniqueness” found in its indigenous communities (Barragán 2011:53). However, the 
multiculturalist turn in the Colombian constitution of 1991 and the weight placed on expeditions to 
“isolated communities” by the GHE made it possible to open up disputes in which indigenous 
groups were recognized as the owners of a certain genetic heritage, leading to the demise of the 
Amerindian biobank project. In the Mexican case, by contrast, mestizaje was represented as a 
positive asset: in the post-Human Genome environment in which the MGDP unfolded (2004-2009), 
medical genetics was rhetorically mobilized as a concrete way to protect both the mestizo and 
indigenous genetic heritage of the nation. The public appropriation of the ‘unique’ genetic 
patrimony of the Mexican mestizo nation by its own government and scientific elites was thus 
represented as a way to reverse the power relations in which ‘developed countries’ would sell 
medicines and biomedical products to the passive markets in the global south (Jiménez-Sánchez 
2002). This nationalistic and sovereign discourse made it possible to make an extensive sampling of 
Mexico’s indigenous communities without any major setback, despite open opposition from 
indigenous activists. 
 
Something of the strong nationalist sentiment informing Mexican genomics is recognizable in the 
answer given by Dr. Jimenez-Sanchez when asked about the special rights and protection of 
indigenous communities: “the protection is the same; finally they are Mexicans, the same as us” 
(interview 2008). This statement would fit less easily in Colombia, in which there is a strong racial-
regional grammar of difference. In the words of the founding figure of Colombian genetics, Emilio 
Yunis- unrelated to the GHE (interview 2012):  
 
Colombia is an ethnic mosaic, a country composed of various nations: one white, another 
black —in the coast—, the indigenous one— living in reservations— and the mestizo one 
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[...] regarding the HE, I do think there is a genetic indigenous patrimony, and that is why 
I defend the fact that indigenous communities should regulate research according to their 
laws and customs. 
 
In sum, the language of racialised regions has become a major prism to represent the Colombian 
nation (Wade 1991), while in Mexico a more homogenising Mestizo identity —albeit highly 
charged with indigenous symbolism— has historically taken root (Basave Benítez 1999). In both 
cases, however, the stubborn racialisation of national imaginaries testifies to the extent to which the 
coloniality of power (Quijano 2000) has been present in the making and disputing of genetic 
populations in Latin America, but also presumably throughout the global south.  
 
Thus, conscious of how global markets and capitalist machinery intertwine with the production of 
biomedicine and genetics research, in both Mexico and Colombia ideas about ethno-racial, national 
and/or geopolitical alterity have been mobilised to face what scientific elites and their public 
opponents have framed as a competitive struggle for the genetic structures of populations 
(sometimes meaning “races”, ethnic groups or nations). In both Mexico and Colombia, ‘genetic 
identities’ and their potential value have played a powerful role in the consolidation of research 
agendas and the quest for funding. At the same time, key scientists, indigenous groups, the ETC and 
policy makers in both Mexico and Colombia have emphasised the potential of genetic 
bioprospecting and biopiracy for reinforcing the scientific and commercial domination of the global 
north in the emerging genetic markets. However, when talking about issues of ‘biopiracy’, both 
critical and scientific voices (unreflexively at some times and strategically at others) leave out of the 
question the racialised categories which are evoked by the disputes on human genetics. By drawing 
attention to this silence, we render visible the workings of biocoloniality.  
 
Drawing on the analytical perspective of coloniality of power (Quijano 2000), the category of 
biocoloniality thus adds depth and complexity to bodies of literature that operate with notions of 
biopolitics that have not been provincialised (Chakrabarty 2000) or decentred. In stark contrast to 
what Nikolas Rose (2008) identifies as the biopolitics of advanced liberal democracies, in which 
autonomous citizens seek to administer and improve their vitality, in Mexico and Colombia there is 
a tendency to link the vital components of ‘ethnic’, ‘racial’  or ‘national’ groups to the global 
political economy of biomedical-genetic research. Seen through the optic of biocoloniality, the 
polities [US and the EU] that Rose (2008) identifies as advanced liberal democracies belong to a 
larger global framework in which ‘biopiracy’ is an issue that cannot be simply ‘othered’. 
Biocoloniality therefore recognises that the global network in which genetic research has gained 
meaning reveals that “there is not a singular ‘politics of life’ but a multiple politics with 
inequalities, opportunities, complexities, and dilemmas both individually and collectively, which 
require a more nuanced exploration” (Raman and Tutton 2010:730). 
 
Against genetic identities: biocoloniality and its implications in political imagination 
 
Notions of genetic ‘uniqueness’ have loomed large in efforts to protect and defend genetic 
patrimonies, despite the fact that, in practice,  both scientific and legal experts have been unable to 
define unequivocal criteria for delimiting such uniqueness (De Vries & Pepper 2012; Schwartz-
Marin & Arellano-Mendez 2012). This has led some scientists – including some of those involved 
in population genetic research in Mexico and Colombia – to express concern about the way in 
which such efforts have been framed. Thus, for instance, some see the law to protect “The Mexican 
Genome” as deeply problematic because there was no way to define in practical terms what was to 
be protected. In the words of Dr. Irma Silva-Zolezzi (interview 2009), first author of the MGDP: 
 
It is technically feasible to speak of sovereignty when we speak about an individual 
genome, which is unique; but to speak of sovereignty over the genome of a whole 
population is pretty difficult. We cannot speak of a unique Mexican genetic structure, 
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when we are talking of shifting percentages of DNA fragments which are shared by 
humanity and various populations across the world. 
 
In Colombia,  Dr. Alberto Gómez —a leading scientist in the HE — affirms that notions such as 
race or categories such as ‘Afrodescendance’ lack any scientific grounding, since races cannot be 
defined genetically and we all come from Africa. He also states that human populations should not 
be represented in terms of percentages of genetic ancestry since a population is by definition in 
constant flux (Gómez in field notes, March 2012). Consequently, twenty years after the HE began, 
leading scientists from this project have questioned their former research categories. Reflecting 
back on the controversies around the HE, Dr. Jaime Bernal —leader of the project and founder of 
IGH-PUJ— thinks that “the sacralisation of genes”, i.e. the idea of genes as bearers of the ultimate 
truth and secrets of humanity (interview 2011), has been a negative issue at the centre of the 
disputes on human genetic research. 
 
Despite such dissenting voices, public debates about the protection of genetic patrimonies from 
neo-colonial exploitation in an emerging biomedical market have continued to be built around the 
idea that indigenous, black or national mestizo populations may possess unique genetic properties.  
Many of the scientists concerned are unable or unwilling to destabilise the idea that genetic 
populations roughly correspond to nations, ethnic groups or, occasionally, races in the public realm. 
Once debate about protecting genetic patrimonies moves into the public realm, scientists and 
legislators alike tend to speak as if genetics possesses the indisputable power to differentiate races, 
individuals, populations and even nations. Biocoloniality, and its rather limited ontological and 
epistemological repertoire, continues to dominate our political and scientific imagination. 
 
Thus in Mexico, the idea that  research on human genetics was the ultimate tool for identifying 
indigenous populations in the interest of medical and economic development was extensively and 
strategically mobilised in the Mexican Congress by the advocates of INMEGEN (IFS 2001: 10-25), 
constituting a regime in which genetics, mestizaje and nation were strongly coupled in public 
discourse (Schwartz-Marin 2011; Schwartz-Marin & Silva-Zolezzi 2010). There was tacit 
agreement, even among the scientists who openly criticised the idea of a “Mexican Genome”, that 
such language made it easier for congressmen to understand the political import of human 
genomics. This led to the “sacralisation” of genetics being written into the legislation preceding the 
creation of the INMEGEN:  
 
With this the idea is to protect only that which is most intimate, which is genetic heredity, from 
external aggression by racist groups and mad personalities, or from multinational entrepreneurs 
without scruples, ready to savagely speculate with the most sacred [part] of the human being: its 
genetic heredity (Patiño in D.O.F. 2001). 
 
In the Colombian case, the controversy around the HE led to new legislation on informed consent 
and “the manipulation of genes”, in large part because genes were thought to be an intimate element 
of human nature, which in the case of indigenous groups (according both to geneticists and to their 
opponents) provided a unique biological signature of humanity’s ancestors.  
 
Such insistence on understanding and ordering the world through a racial matrix reproduces well-
known divisions and colonial struggles for property, control and justice. As TallBear and Reardon 
(2012) have stated in a recent paper exploring the role of whiteness as property in genomic 
research, US scientists’ practice of ownership and sharing of indigenous tissue samples reinforces 
“white” privilege. However we should be as critical of the reification of race [and its consequences] 
in the public realm as in laboratories: NGOs, indigenous representatives and critical voices too 
readily accept that there is a Havasupai, Tepehuano or Inca DNA. Does avoiding racialisation and 
the reification of DNA mean we should accept a universalising discourse in which the scientists that 
own the genetic sequencers can profit from, and freely study indigenous communities as they 
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please? Our answer is an emphatic “No”. There are ways to build a more balanced relation between 
genetic science and indigenous communities, beyond those that geneticise collective identities.  
 
First, we need to recognise the technical and ethical impossibility of isolating and defending 
indigenous, national or racial genes – as do many genetic scientists nowadays. We also need to 
recognise that the characterisation and valorisation of ‘indigenous’ DNA does not proceed in 
geographical isolation, but depends on dialogues with the many population DNA databases that 
exist around the globe, including those in the global north. Once this is understood, we will not 
need to waste any more precious time trying to police and control ‘indigenous’ DNA. Rather, we 
need to look for more horizontal relationships between genetic scientists and the communities that 
participate in their studies, beyond those that sacralise genetic heritage.   
 
Most importantly, there is an urgent need to develop serious and robust governance mechanisms for 
genomic research. At the moment both Mexico and Colombia lack independent bioethical bodies to 
deal with these matters.  In Colombia, while there are indigenous representatives in the Congress, 
twenty years after the HE project finished no advances have been made to put the law regarding 
informed consent into practice. In the case of Mexico, INMEGEN’s central role in genomic 
research and the design and sanction of the law on Genomic Sovereignty have only fuelled a 
generalised competition to control samples amongst scientists. This leaves to one side the main 
preoccupation behind the creation of the INMEGEN and the law on Genomic Sovereignty, which 
was to make population genetic science a public health resource. 
 
The relations between modernity and colonialism emerge not only as violent practices of 
domination and subjugation, but are present in the very categories we use to understand and dispute 
our world. In the field of population genomics, one of the main difficulties comes from the very 
communication strategies scientists and their audiences (some of them extremely critical) use to 
refer to human genetic research, and the always-prickly question of what exactly constitutes a 
population. With almost 3,200 million base pairs in the human genome, the possibilities of making 
statistically significant groupings are much greater than just talking about African, Amerindian, 
Asian, Mestizo or European ancestries (see Fausto-Sterling 2005). The very fact that the genetic 
partition of human diversity is still conceptualised in terms of continental-racial groups, bears 
witness to the intricate relationship between science, modernity and sedimented notions of 
difference.  
 
The modern constitution in which scientists are the only ones accredited to speak for non-humans or 
give voice to the natural world, while politicians and activist deal with passions, opinions and 
interpretations, has impoverished our political possibilities for far too long. Political alternatives of 
contestation would change drastically if, instead of thinking in terms of extracting “indigenous 
genes,” activists and NGOs could destabilise and question the existence of such entities in the first 
place. How these political disputes will look in the upcoming future is a question that only 
experimentation can answer. In the meantime, the recognition and critical appraisal of the way in 
which biocoloniality operates in our world might help us in the construction of new political and 
scientific alternatives. 
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